1119 |
(Korea): Present a Complex PCI of DM and LM Patient |
June Hong Kim |
May. 12. 11 |
1118 |
How We Treat MVD Patient with CTO in Malaysia and Improve Outcomes with These Challenging Procedures |
Amin Ariff Nuruddin |
May. 12. 11 |
1117 |
I Do Not Need Any Scoring ! |
Antonio Colombo |
May. 12. 11 |
1116 |
SYNTAX Scoring Before Decision-making ! |
Chung-Ho Hsu |
May. 12. 11 |
1115 |
It's Not Enough ! |
Seung-Jung Park |
May. 12. 11 |
1114 |
Angiographic Guidance Is Enough ! |
Yves R. Louvard |
May. 12. 11 |
1113 |
Role of Genotyping and Point-of-Care Testing in Clopidogrel, Parsugrel, and Ticagrelor |
Ron Waksman |
May. 12. 11 |
1112 |
Impact of Bleeding and Tailored or Personalized Antiplatlet Therapy to Reduce Bleeding in ACS or PCI Patients: From Clopidogrel to Prasugrel and Ticagrelor |
Roxana Mehran |
May. 12. 11 |
1111 |
Optimal Regiment or Duration of Anti-platelet Therapy: Dual vs Triple, 6 vs 12 Months |
Hyo-Soo Kim |
May. 12. 11 |
1110 |
Pharmacogenetic Debates in Antiplatelet Therapy |
Guillaume Pare |
May. 12. 11 |